The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
作者信息
Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B, Poppe B, De Paepe A, De Grève J
出版信息
J Med Genet. 2004 Mar;41(3):e23. doi: 10.1136/jmg.2003.011353.
Abstract
摘要
相似文献
1
The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
J Med Genet. 2004 Mar;41(3):e23. doi: 10.1136/jmg.2003.011353.
2
Pretest genetic counseling informs patients with BRCA mutation.
Cancer. 2012 Dec 15;118(24):6017. doi: 10.1002/cncr.27922.
3
Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Fam Cancer. 2005;4(2):115-9. doi: 10.1007/s10689-004-7991-2.
4
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
J Natl Cancer Inst. 2002 Jun 5;94(11):844-51. doi: 10.1093/jnci/94.11.844.
5
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Breast Cancer Res Treat. 2013 Aug;141(1):135-44. doi: 10.1007/s10549-013-2669-9. Epub 2013 Aug 24.
6
Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
Fam Cancer. 2010 Sep;9(3):297-304. doi: 10.1007/s10689-009-9313-1.
7
Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.
Clin Genet. 2005 Jun;67(6):492-502. doi: 10.1111/j.1399-0004.2005.00443.x.
8
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243.
9
Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Cancer Control. 2004 Jul-Aug;11(4):236-44. doi: 10.1177/107327480401100405.
10
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Breast Cancer Res. 2006;8(1):R3. doi: 10.1186/bcr1365. Epub 2005 Dec 12.
引用本文的文献
1
Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study.
Fam Cancer. 2025 Feb 26;24(1):25. doi: 10.1007/s10689-025-00450-2.
2
Investigating genetic counselors' communication with Lynch syndrome patients about cascade testing: Barriers, facilitators, and strategies.
J Genet Couns. 2025 Apr;34(2):e1937. doi: 10.1002/jgc4.1937. Epub 2024 Jul 4.
3
Cascade genetic testing: an underutilized pathway to equitable cancer care?
Fam Cancer. 2024 Jun;23(2):141-145. doi: 10.1007/s10689-024-00367-2. Epub 2024 May 15.
4
Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy.
Genes (Basel). 2022 Jul 21;13(7):1286. doi: 10.3390/genes13071286.
5
Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers.
Appl Clin Genet. 2021 Jan 14;14:1-9. doi: 10.2147/TACG.S245021. eCollection 2021.
6
Facilitated cascade testing (FaCT): a randomized controlled trial.
Int J Gynecol Cancer. 2021 May;31(5):779-783. doi: 10.1136/ijgc-2020-002118. Epub 2020 Dec 18.
7
Barriers and facilitators for cascade testing in genetic conditions: a systematic review.
Eur J Hum Genet. 2020 Dec;28(12):1631-1644. doi: 10.1038/s41431-020-00725-5. Epub 2020 Sep 18.
8
Does family communication matter? Exploring knowledge of breast cancer genetics in cancer families.
J Community Genet. 2019 Oct;10(4):481-487. doi: 10.1007/s12687-019-00413-y. Epub 2019 Mar 15.
9
Disparities in gynecologic cancer genetics evaluation.
Gynecol Oncol. 2019 Apr;153(1):184-191. doi: 10.1016/j.ygyno.2019.01.024. Epub 2019 Jan 31.
10
The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Fam Cancer. 2019 Jan;18(1):127-135. doi: 10.1007/s10689-018-0089-z.
Zotero 插件